The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,123.00
Bid: 1,132.00
Ask: 1,134.00
Change: -53.00 (-4.51%)
Spread: 2.00 (0.177%)
Open: 1,200.00
High: 1,200.00
Low: 1,117.00
Prev. Close: 1,176.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 Portfolio Progress & Full Year Results 2019

28 Apr 2020 07:00

RNS Number : 1232L
Burford Capital Limited
28 April 2020
 

This announcement contains inside information

 

28 April 2020

 

 

BURFORD CAPITAL REPORTS 2020 PORTFOLIO PROGRESS, STRONG 2019 GROWTH AND ROBUST CASH GENERATION

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today announces an update on its 2020 portfolio progress and its financial results for the year ended 31 December 2019, which are consistent with the guidance provided in our 3 February 2020 trading update. Burford's complete annual report and audited accounts, which are significantly expanded this year, are available at http://www.rns-pdf.londonstockexchange.com/rns/1232L_1-2020-4-28.pdf or the Burford website: www.burfordcapital.com.

 

2020 Portfolio progress

 

On 3 February 2020, Burford reported that it had achieved litigation successes that would trigger unrealized gains and, if ultimately affirmed and paid, would generate more than $150 million in Group-wide income and more than $100 million in balance sheet income.

 

Since then, Burford has enjoyed further substantial successes in its portfolio. In the first four months of 2020 Burford has obtained court results or arbitral awards that, if paid in full, would generate substantial income and cash receipts:

 

· Almost $800 million in Group-wide cash receipts and more than $450 million in balance sheet cash receipts

 

· More than $500 million in Group-wide income and approximately $300 million in balance sheet income, against which less than $1.5 million had been realised through 31 December 2019 in balance sheet fair value gains

 

· As a subset of the foregoing, more than $300 million in balance sheet cash receipts and $200 million in balance sheet income either in the form of arbitral awards or appellate court judgments from which further legal review is unlikely ("Final Matters"), and if not paid promptly will result in the creation of substantial unrealised gain or receivables while payment is awaited

 

The expected cash receipts should provide a meaningful addition to Burford's already healthy cash liquidity to reinvest in new matters.

 

The balance sheet numbers above do not include future balance sheet entitlement to performance fees on what would be more than $200 million in fund income, $150 million of which in Final Matters.

 

It is noteworthy that, in just the first four months of 2020, Burford has seen several significant case successes that if ultimately affirmed and paid would generate meaningful profits and cash receipts. This is in keeping with our commentary in our annual report (at pages 54-55) about the unpredictability of the timing of outcomes but the ultimate delivery of performance.

 

Risk remains in litigation until matters actually pay cash, and it is always possible that the anticipated income described above will be reduced by further court action, prepayment discounts or by agreement between the parties.

 

2019 Financial highlights1

 

· Sustained client demand for Burford's capital saw 29% growth in core litigation finance and asset recovery new commitments to $955 million (2018: $739 million)

o Total commitments reached a new all-time high of $1.6 billion, up 19%

o Deployments exceeded $1 billion for the third year in a row

o Burford's portfolio grew to $4.2 billion (2018: $3.2 billion)

 

· Burford generated more than $1 billion in cash in 2019, with $518 million on Burford's balance sheet (2018: $526 million)

o Balance sheet cash receipts were more than 4x operating expenses and finance costs, leaving $397 million available for distribution or deployment into new legal finance assets

 

· Return on invested capital in balance sheet core litigation finance portfolio rose from 85% to 93% for an IRR of 31%

 

· Quiet second half for asset realisations drove lower Burford-only adjusted operating profit of $279 million (2018: $355 million) and lower profit after tax of $226 million (2018: $329 million); operating margin of 78%

 

· Total Burford-only income was down 15% at $357 million (2018: $420 million)

o As indicated in our 3 February 2020 trading update, net realised gains were $28 million lower than in 2018 (trading update range: $20-30 million lower) and net unrealised gains were $52 million lower than in 2018 (trading update range: $50-70 million lower)

o Unrealised gains as a share of total income decreased to 52% (2018: 57%) 

 

· Over $200 million in balance sheet cash and cash management assets at year end 2019, plus $185 million in capital provision indirect assets with relatively short average lives, providing ample liquidity to manage COVID-19 environment

 

· Burford's private funds saw total assets under management rise to $2.9 billion (2018: $2.5 billion), generating $26 million of income, up 65%, on AUM growth and $7.1 million of income from our sovereign wealth fund arrangement

 

[1] Figures for total income, operating profit, profit before tax and profit after tax in this release exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost, and third-party interests in consolidated entities, and are shown to assist understanding of the underlying performance of the Company.

 

Sir Peter Middleton, Chairman of Burford, commented:

 

"2019 was a year of contrasts, marked by the continued expansion of our business yet also by the disruption of a meritless short attack. Though our business fundamentals remained strong, investor confidence was dented, causing shareholders to urge changes to our governance. We responded by restructuring our Board, including nominating new directors, appointing a new CFO and reorganising our senior management, and announcing a plan to seek a dual share listing in the US. In addition, we have continued to increase and improve the transparency of our disclosure. I believe Burford will emerge stronger than ever, with a significantly increased capability to sustain its leadership of the global legal finance industry into the firm's second decade."

 

Christopher Bogart, Chief Executive Officer of Burford, added:

 

"Against the measure of success of growing Burford's business and generating substantial free cash, Burford had a spectacular year, and 2020 is off to a terrific start. We are the market leader in a rapidly growing industry with high and uncorrelated returns, and we expect meaningful demand for our services in light of the current economic disruption. We have significant cash on hand in addition to our proven cash generating capacity and access to hundreds of millions of dollars of fund capital to boot. And much as we share the world's distress at our current health crisis, the reality is that we expect its aftermath to be a time of significant demand for our services and a moment when uncorrelated cash flows are especially attractive."

 

COVID-19

 

Burford has provided at page 73 of its annual report an extensive discussion about the risks and opportunities to its business from the current COVID-19 pandemic and what we expect to be an ensuing economic downturn. In short, while the pandemic could well result in delays in the realisation of Burford's assets, those delays are timing rather than substantive and the risks to Burford's business are considerably less than many other companies, while also creating the likelihood of business opportunities going forward.

 

Financial Summary

 

A financial summary of Burford's results is set out below. As usual, this summary is presented without third-party interests in Burford's consolidated entities and after certain adjustments to assist in understanding the underlying performance of the Company.

 

 

 

 

2019

 

2018

% change

 

 

$'000

 

$'000

 

 

 

 

 

 

 

Capital provision income

 

316,780

 

392,525

 

Asset management income

 

26,130

 

15,799

 

Services and other income

 

13,800

 

12,050

 

 

 

 

 

 

 

Total income*

 

356,710

 

420,374

-15%

 

 

 

 

 

 

Operating expenses

 

(77,412)

 

(65,494)

 

 

 

 

 

 

 

Operating profit*

 

279,298

 

354,880

-21%

 

 

 

 

 

 

Finance costs

 

(39,622)

 

(38,538)

 

 

 

 

 

 

 

Profit before tax*

 

239,676

 

316,342

-24%

 

 

 

 

 

 

Taxation

 

(13,417)

 

12,463

 

 

 

 

 

 

 

Profit after tax*

 

226,259

 

328,805

-31%

 

 

 

 

 

 

* Total income, operating profit, profit before tax and profit after tax exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost, and third-party interests in consolidated entities.

Investor and Analyst Conference Call

 

Burford will host a conference call for investors and analysts at 2.00pm (British Summer Time) / 9.00am (Eastern Daylight Time) on Tuesday 28 April 2020.

 

Burford encourages investors and analysts to pre-register for dedicated audio webcast access via:

https://www.investis-live.com/burfordcapital/5e6113f2fe2c790a007aaf4e/kgfd.

 

The dial-in number for the conference call is +44 (0)20 3936 2999 / +1 646 664 1960 and the access code is 916118.

 

An accompanying presentation will be available on the Burford Capital website: http://www.burfordcapital.com/investors.

 

A replay facility will be available until Tuesday 12 May 2020 by dialling +44 (0)20 3936 3001 / +1 845 709 8569 with the replay code 047970.

 

Share issuance for LTIP awards

 

In connection with the delivery of vested LTIP awards to employees the Company has allotted and issued 400,000 new Ordinary Shares of nil par value each in the capital of the Company (the "New Shares"). Application has been made to the London Stock Exchange plc for admission to trading of the New Shares on AIM ("Admission"). The Admission is expected to take place at 8.00am (British Summer Time) on 29 April 2020.

 

Following admission of the New Shares the Company will have 219,049,877 Ordinary Shares of nil par value each in issue. There are no shares held in treasury. Therefore, following admission of the New Shares the total number of voting rights in the Company will be 219,049,877 (the "Voting Rights Figure"), and this Voting Rights Figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company.

 

Corporate calendar

 

Burford will hold its AGM on 13 May 2020.

 

Given (i) the delay in the release of Burford's FY 2019 results due to COVID-19; (ii) the continuing backlog of audit work; and (iii) the process associated with Burford's US listing , Burford anticipates releasing its interim results for the period ended 30 June 2020 later than usual, and perhaps as late as the latter part of September 2020. If Burford releases its interim results prior to obtaining a US listing, that would cause further delay in the listing process as the interim results will need to be incorporated into a revised registration statement.

 

 

For further information, please contact:

 

Burford Capital Limited

 

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

 

Alex Reynolds

 

 

 

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

 

Tony White

 

 

 

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

 

Jonathan Abbott

 

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR DZGZDDRLGGZG
Date   Source Headline
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.